Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...
8don MSN
The changes at Spark follow Roche's decision last year to halt development of a gene therapy for hemophilia A that was the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback